Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Voyager Therapeutics (VYGR) Amortizatization of Intangibles (2016 - 2025)

Voyager Therapeutics' Amortizatization of Intangibles history spans 11 years, with the latest figure at $2.4 million for Q4 2025.

  • For Q4 2025, Amortizatization of Intangibles fell 46.59% year-over-year to $2.4 million; the TTM value through Dec 2025 reached $4.9 million, down 38.88%, while the annual FY2025 figure was $4.9 million, 38.88% down from the prior year.
  • Amortizatization of Intangibles for Q4 2025 was $2.4 million at Voyager Therapeutics, up from $654000.0 in the prior quarter.
  • Across five years, Amortizatization of Intangibles topped out at $4.5 million in Q4 2024 and bottomed at -$972000.0 in Q3 2024.
  • The 5-year median for Amortizatization of Intangibles is $22000.0 (2022), against an average of $806650.0.
  • The largest annual shift saw Amortizatization of Intangibles crashed 154.26% in 2021 before it soared 41625.0% in 2024.
  • A 5-year view of Amortizatization of Intangibles shows it stood at -$25000.0 in 2021, then soared by 72.0% to -$7000.0 in 2022, then skyrocketed by 25728.57% to $1.8 million in 2023, then soared by 153.4% to $4.5 million in 2024, then plummeted by 46.59% to $2.4 million in 2025.
  • Per Business Quant, the three most recent readings for VYGR's Amortizatization of Intangibles are $2.4 million (Q4 2025), $654000.0 (Q3 2025), and $791000.0 (Q2 2025).